Medidata Solutions, Inc. (MDSO ) Misses Q3 EPS by 7c; Guides FY12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St to open lower as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Nvidia releases AI safety software it says could have stopped Hugging Face hack
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Jefferies Reiterates Buy on Medidata (MDS) as Deals Roll In
November 1, 2012 2:09 PM EDTJefferies reiterated a Buy on Medidata Solutions (NASDAQ: MDSO) and raised its price target to $48.50 (from $41.00). Medidata Solutions is global provider of hosted clinical development solutions designed to improve the efficiency of the clinical development process.
Commenting on the company's recent earning release,... More
Piper Jaffray Upgrades Medidata Solutions (MDSO) to Overweight
November 1, 2012 6:46 AM EDTPiper Jaffray upgraded Medidata Solutions (NASDAQ: MDSO) from Neutral to Overweight with a price target of $54.00 (from $31.00) following Q3 results.
For an analyst ratings summary and ratings history on Medidata Solutions click here.... More
